pubmed-article:15797738 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15797738 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:15797738 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
pubmed-article:15797738 | lifeskim:mentions | umls-concept:C0035015 | lld:lifeskim |
pubmed-article:15797738 | lifeskim:mentions | umls-concept:C1302234 | lld:lifeskim |
pubmed-article:15797738 | lifeskim:mentions | umls-concept:C1882923 | lld:lifeskim |
pubmed-article:15797738 | lifeskim:mentions | umls-concept:C1548437 | lld:lifeskim |
pubmed-article:15797738 | lifeskim:mentions | umls-concept:C0814225 | lld:lifeskim |
pubmed-article:15797738 | lifeskim:mentions | umls-concept:C0600558 | lld:lifeskim |
pubmed-article:15797738 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
pubmed-article:15797738 | lifeskim:mentions | umls-concept:C0205393 | lld:lifeskim |
pubmed-article:15797738 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:15797738 | pubmed:dateCreated | 2005-3-30 | lld:pubmed |
pubmed-article:15797738 | pubmed:abstractText | Induction immunosuppression utilizing lymphocytolytic agents in the early peri-operative period has a number of theoretical and practical advantages and disadvantages. However, the efficacy of cytolytic agents as induction therapy remains unproven. | lld:pubmed |
pubmed-article:15797738 | pubmed:language | eng | lld:pubmed |
pubmed-article:15797738 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15797738 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15797738 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15797738 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15797738 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15797738 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15797738 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15797738 | pubmed:month | Apr | lld:pubmed |
pubmed-article:15797738 | pubmed:issn | 1053-2498 | lld:pubmed |
pubmed-article:15797738 | pubmed:author | pubmed-author:MillerLL | lld:pubmed |
pubmed-article:15797738 | pubmed:author | pubmed-author:HigginsRR | lld:pubmed |
pubmed-article:15797738 | pubmed:author | pubmed-author:OrenRR | lld:pubmed |
pubmed-article:15797738 | pubmed:author | pubmed-author:KirklinJ KJK | lld:pubmed |
pubmed-article:15797738 | pubmed:author | pubmed-author:BrownR NRN | lld:pubmed |
pubmed-article:15797738 | pubmed:author | pubmed-author:BourgeR CRC | lld:pubmed |
pubmed-article:15797738 | pubmed:author | pubmed-author:RayburnB KBK | lld:pubmed |
pubmed-article:15797738 | pubmed:author | pubmed-author:FlatteryMM | lld:pubmed |
pubmed-article:15797738 | pubmed:author | pubmed-author:WagonerLL | lld:pubmed |
pubmed-article:15797738 | pubmed:author | pubmed-author:Cardiac... | lld:pubmed |
pubmed-article:15797738 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15797738 | pubmed:volume | 24 | lld:pubmed |
pubmed-article:15797738 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15797738 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15797738 | pubmed:pagination | 392-400 | lld:pubmed |
pubmed-article:15797738 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:15797738 | pubmed:meshHeading | pubmed-meshheading:15797738... | lld:pubmed |
pubmed-article:15797738 | pubmed:meshHeading | pubmed-meshheading:15797738... | lld:pubmed |
pubmed-article:15797738 | pubmed:meshHeading | pubmed-meshheading:15797738... | lld:pubmed |
pubmed-article:15797738 | pubmed:meshHeading | pubmed-meshheading:15797738... | lld:pubmed |
pubmed-article:15797738 | pubmed:meshHeading | pubmed-meshheading:15797738... | lld:pubmed |
pubmed-article:15797738 | pubmed:meshHeading | pubmed-meshheading:15797738... | lld:pubmed |
pubmed-article:15797738 | pubmed:meshHeading | pubmed-meshheading:15797738... | lld:pubmed |
pubmed-article:15797738 | pubmed:meshHeading | pubmed-meshheading:15797738... | lld:pubmed |
pubmed-article:15797738 | pubmed:meshHeading | pubmed-meshheading:15797738... | lld:pubmed |
pubmed-article:15797738 | pubmed:meshHeading | pubmed-meshheading:15797738... | lld:pubmed |
pubmed-article:15797738 | pubmed:meshHeading | pubmed-meshheading:15797738... | lld:pubmed |
pubmed-article:15797738 | pubmed:meshHeading | pubmed-meshheading:15797738... | lld:pubmed |
pubmed-article:15797738 | pubmed:meshHeading | pubmed-meshheading:15797738... | lld:pubmed |
pubmed-article:15797738 | pubmed:meshHeading | pubmed-meshheading:15797738... | lld:pubmed |
pubmed-article:15797738 | pubmed:meshHeading | pubmed-meshheading:15797738... | lld:pubmed |
pubmed-article:15797738 | pubmed:meshHeading | pubmed-meshheading:15797738... | lld:pubmed |
pubmed-article:15797738 | pubmed:meshHeading | pubmed-meshheading:15797738... | lld:pubmed |
pubmed-article:15797738 | pubmed:meshHeading | pubmed-meshheading:15797738... | lld:pubmed |
pubmed-article:15797738 | pubmed:meshHeading | pubmed-meshheading:15797738... | lld:pubmed |
pubmed-article:15797738 | pubmed:meshHeading | pubmed-meshheading:15797738... | lld:pubmed |
pubmed-article:15797738 | pubmed:meshHeading | pubmed-meshheading:15797738... | lld:pubmed |
pubmed-article:15797738 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:15797738 | pubmed:articleTitle | To induce or not to induce: do patients at greatest risk for fatal rejection benefit from cytolytic induction therapy? | lld:pubmed |
pubmed-article:15797738 | pubmed:affiliation | University of Alabama at Birmingham, Division of Cardiothoracic Surgery, Birmingham, Alabama 35294, USA. | lld:pubmed |
pubmed-article:15797738 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15797738 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:15797738 | pubmed:publicationType | Multicenter Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15797738 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15797738 | lld:pubmed |